FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE

FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE was reported 36209 times

These side effects are most commonly reported by patients taking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE:

# Side effect Count
0 DYSPNOEA 6235
1 DRUG INEFFECTIVE 4089
2 ASTHMA 4061
3 COUGH 3458
4 WHEEZING 2688
5 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2341
6 PNEUMONIA 2247
7 PRODUCT COMPLAINT 1882
8 PRODUCT DOSE OMISSION ISSUE 1827
9 FATIGUE 1769
10 OFF LABEL USE 1587
11 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1553
12 MALAISE 1479
13 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1395
14 HEADACHE 1363
15 NAUSEA 1319
16 DIZZINESS 1248
17 DYSPHONIA 1240
18 CHEST DISCOMFORT 1205
19 PRODUCTIVE COUGH 1181
20 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1125
21 CONDITION AGGRAVATED 1116
22 PRODUCT USE IN UNAPPROVED INDICATION 1083
23 OBSTRUCTIVE AIRWAYS DISORDER 1070
24 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1041
25 DIARRHOEA 1015
26 PAIN 990
27 DEATH 892
28 DRUG DOSE OMISSION 871
29 VOMITING 851
30 ASTHENIA 850
31 NASOPHARYNGITIS 849
32 BRONCHITIS 844
33 FALL 843
34 RASH 827
35 PRODUCT QUALITY ISSUE 822
36 ANXIETY 807
37 DEVICE USE ERROR 793
38 ARTHRALGIA 792
39 OROPHARYNGEAL PAIN 762
40 PAIN IN EXTREMITY 752
41 PRURITUS 751
42 DYSPNOEA EXERTIONAL 745
43 SINUSITIS 700
44 HYPERTENSION 696
45 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 694
46 CHEST PAIN 691
47 PRODUCT DOSE OMISSION 673
48 WEIGHT DECREASED 672
49 INSOMNIA 663
50 GASTROOESOPHAGEAL REFLUX DISEASE 634
51 PRODUCT USE ISSUE 629
52 FEELING ABNORMAL 618
53 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 613
54 COVID-19 612
55 HOSPITALISATION 592
56 INFLUENZA 590
57 OVERDOSE 587
58 PYREXIA 584
59 BLOOD PRESSURE INCREASED 581
60 NASAL CONGESTION 581
61 FULL BLOOD COUNT ABNORMAL 574
62 ABDOMINAL PAIN 563
63 RHINORRHOEA 542
64 BACK PAIN 522
65 BLOOD COUNT ABNORMAL 522
66 HYPERSENSITIVITY 521
67 CONSTIPATION 518
68 WEIGHT INCREASED 503
69 URTICARIA 481
70 HEART RATE INCREASED 470
71 OEDEMA PERIPHERAL 469
72 ILLNESS 466
73 DEPRESSION 460
74 DRUG HYPERSENSITIVITY 459
75 SPUTUM DISCOLOURED 456
76 LUNG DISORDER 448
77 PERIPHERAL SWELLING 444
78 THROAT IRRITATION 442
79 URINARY TRACT INFECTION 438
80 GAIT DISTURBANCE 425
81 INTENTIONAL PRODUCT MISUSE 422
82 ABDOMINAL PAIN UPPER 418
83 ATRIAL FIBRILLATION 418
84 DRUG DISPENSING ERROR 416
85 EXTRA DOSE ADMINISTERED 412
86 BRONCHIECTASIS 403
87 PALPITATIONS 403
88 CANDIDA INFECTION 398
89 UNDERDOSE 398
90 MYOCARDIAL INFARCTION 396
91 TREMOR 392
92 DRY MOUTH 377
93 MUSCLE SPASMS 374
94 DECREASED APPETITE 373
95 OXYGEN SATURATION DECREASED 372
96 LOWER RESPIRATORY TRACT INFECTION 366
97 INCORRECT DOSE ADMINISTERED 362
98 INFECTION 349
99 SLEEP APNOEA SYNDROME 347
100 NASAL POLYPS 346
101 DRUG INTOLERANCE 337
102 VISION BLURRED 333
103 SOMNOLENCE 329
104 PULMONARY EMBOLISM 328
105 LUNG NEOPLASM MALIGNANT 325
106 SLEEP DISORDER 319
107 ABDOMINAL DISCOMFORT 317
108 MIGRAINE 317
109 INJECTION SITE PAIN 316
110 PRODUCT DISPENSING ERROR 312
111 OSTEOPOROSIS 309
112 UPPER RESPIRATORY TRACT INFECTION 306
113 MYALGIA 305
114 DYSPEPSIA 300
115 ABDOMINAL DISTENSION 293
116 MIDDLE INSOMNIA 289
117 ANAEMIA 288
118 PRODUCT LABEL CONFUSION 288
119 ILL-DEFINED DISORDER 281
120 DIABETES MELLITUS 274
121 CARDIAC FAILURE CONGESTIVE 270
122 THROMBOSIS 269
123 CARDIAC DISORDER 268
124 CATARACT 266
125 CEREBROVASCULAR ACCIDENT 266
126 JOINT SWELLING 263
127 CHILLS 260
128 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 259
129 PRESCRIBED OVERDOSE 257
130 SEPSIS 256
131 STRESS 251
132 HYPOAESTHESIA 250
133 HYPOTENSION 248
134 SWELLING 245
135 PULMONARY MASS 243
136 STOMATITIS 241
137 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 240
138 HYPERHIDROSIS 237
139 RESPIRATORY DISORDER 237
140 VISUAL IMPAIRMENT 236
141 SEASONAL ALLERGY 232
142 HAEMOPTYSIS 230
143 ERYTHEMA 226
144 ARTHRITIS 225
145 EXPIRED PRODUCT ADMINISTERED 224
146 ORAL CANDIDIASIS 221
147 EMPHYSEMA 220
148 PRODUCT STORAGE ERROR 218
149 FORCED EXPIRATORY VOLUME DECREASED 217
150 CONTUSION 216
151 FLUID RETENTION 215
152 ADVERSE DRUG REACTION 213
153 DYSPHAGIA 213
154 PARAESTHESIA 213
155 APHONIA 209
156 RESPIRATORY TRACT CONGESTION 209
157 INTENTIONAL PRODUCT USE ISSUE 208
158 UPPER-AIRWAY COUGH SYNDROME 206
159 MEMORY IMPAIRMENT 203
160 RENAL FAILURE 198
161 THERAPEUTIC RESPONSE DECREASED 198
162 DEHYDRATION 196
163 SECRETION DISCHARGE 194
164 BLOOD TEST ABNORMAL 193
165 RHINITIS ALLERGIC 188
166 EOSINOPHIL COUNT INCREASED 186
167 GASTROINTESTINAL DISORDER 186
168 CARDIAC MURMUR 185
169 SINUS DISORDER 185
170 NEUROPATHY PERIPHERAL 184
171 RESPIRATORY SYMPTOM 184
172 GENERAL PHYSICAL HEALTH DETERIORATION 183
173 ACUTE KIDNEY INJURY 182
174 MUSCULAR WEAKNESS 182
175 DRUG EFFECT INCOMPLETE 180
176 PRODUCT PACKAGING CONFUSION 179
177 HIATUS HERNIA 177
178 GOUT 176
179 INTENTIONAL UNDERDOSE 176
180 OSTEOARTHRITIS 176
181 CYSTITIS 175
182 FUNGAL INFECTION 175
183 HYPOXIA 175
184 TACHYCARDIA 175
185 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 174
186 RESPIRATORY TRACT INFECTION 173
187 ECZEMA 172
188 IMPAIRED QUALITY OF LIFE 169
189 SARCOIDOSIS 169
190 LOSS OF CONSCIOUSNESS 168
191 DISEASE RECURRENCE 166
192 PULMONARY FUNCTION TEST ABNORMAL 166
193 PULMONARY FIBROSIS 165
194 ALOPECIA 164
195 BACTERIAL INFECTION 164
196 BLOOD GLUCOSE INCREASED 164
197 MULTIPLE ALLERGIES 164
198 MUSCULOSKELETAL STIFFNESS 164
199 SYNCOPE 162
200 CONFUSIONAL STATE 161
201 DYSGEUSIA 160
202 TINNITUS 160
203 NERVOUSNESS 159
204 PLEURAL EFFUSION 159
205 HALLUCINATION 158
206 EOSINOPHILIA 157
207 HYPOACUSIS 157
208 DRY SKIN 155
209 HEART RATE DECREASED 155
210 TOTAL LUNG CAPACITY INCREASED 154
211 CHRONIC KIDNEY DISEASE 152
212 OEDEMA 151
213 THERAPEUTIC RESPONSE UNEXPECTED 151
214 AGITATION 150
215 INTENTIONAL DOSE OMISSION 150
216 EAR INFECTION 149
217 PULMONARY CONGESTION 149
218 EPISTAXIS 148
219 BRONCHIAL WALL THICKENING 147
220 DERMATITIS ATOPIC 147
221 NO ADVERSE EVENT 147
222 BALANCE DISORDER 145
223 SURGERY 145
224 RHEUMATOID ARTHRITIS 144
225 VIRAL INFECTION 144
226 FIBROMYALGIA 143
227 PULMONARY FUNCTION TEST DECREASED 141
228 INABILITY TO AFFORD MEDICATION 140
229 HERPES ZOSTER 139
230 NECK PAIN 139
231 DISCOMFORT 138
232 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 138
233 INJECTION SITE ERYTHEMA 138
234 SEIZURE 138
235 SINUS CONGESTION 138
236 EYE PAIN 136
237 HEPATIC ENZYME INCREASED 136
238 CELLULITIS 134
239 SNEEZING 134
240 CHOLELITHIASIS 132
241 DUST ALLERGY 132
242 FEELING HOT 132
243 NEURALGIA 132
244 OCULAR HYPERAEMIA 132
245 BLOOD CHOLESTEROL INCREASED 131
246 PULMONARY OEDEMA 131
247 MOBILITY DECREASED 129
248 RHINITIS 129
249 DIASTOLIC DYSFUNCTION 128
250 EYE IRRITATION 127
251 CHOKING 126
252 HYPOTHYROIDISM 126
253 DRY EYE 125
254 INFLUENZA LIKE ILLNESS 125
255 CHRONIC SINUSITIS 123
256 ORAL PAIN 123
257 DRUG EFFECT DECREASED 122
258 DRUG PRESCRIBING ERROR 122
259 BREATH SOUNDS ABNORMAL 121
260 SWELLING FACE 120
261 PSORIASIS 118
262 HOT FLUSH 117
263 PSYCHOTIC DISORDER 116
264 ADVERSE EVENT 115
265 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 115
266 EYE PRURITUS 115
267 FLUSHING 115
268 SWOLLEN TONGUE 115
269 AGEUSIA 114
270 BLOOD BILIRUBIN INCREASED 114
271 BLOOD PRESSURE DECREASED 114
272 LYMPHOEDEMA 114
273 SPUTUM INCREASED 114
274 ARTERIOSCLEROSIS CORONARY ARTERY 113
275 BRONCHIAL OBSTRUCTION 111
276 HAEMOGLOBIN DECREASED 111
277 PRODUCT PRESCRIBING ERROR 111
278 OESOPHAGEAL PAIN 110
279 TREATMENT NONCOMPLIANCE 110
280 BONE PAIN 108
281 END STAGE RENAL DISEASE 108
282 HYPONATRAEMIA 107
283 RESPIRATORY FAILURE 107
284 SPEECH DISORDER 107
285 THERAPY INTERRUPTED 107
286 DEVICE MALFUNCTION 106
287 DISEASE PROGRESSION 106
288 DRUG INTERACTION 106
289 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 106
290 UNEVALUABLE EVENT 106
291 BENIGN PROSTATIC HYPERPLASIA 105
292 INFUSION SITE PAIN 105
293 NEPHROLITHIASIS 105
294 VERTIGO 105
295 DEEP VEIN THROMBOSIS 104
296 HEPATOTOXICITY 104
297 INJECTION SITE SWELLING 104
298 JOINT INJURY 104
299 BURNING SENSATION 103
300 HAEMORRHAGE 103
301 HEAD INJURY 103
302 SCHIZOPHRENIA 103
303 NEOPLASM MALIGNANT 102
304 THROAT TIGHTNESS 102
305 LARYNGITIS 101
306 OBSTRUCTION 101
307 AMNESIA 100
308 ANAPHYLACTIC REACTION 100
309 INCREASED BRONCHIAL SECRETION 100
310 NODULE 100
311 SKIN EXFOLIATION 100
312 ASCITES 99
313 JAUNDICE CHOLESTATIC 99
314 OBESITY 99
315 OESOPHAGEAL SPASM 99
316 FEELING JITTERY 98
317 CONJUNCTIVITIS ALLERGIC 97
318 LACRIMATION INCREASED 97
319 MEDICATION ERROR 97
320 RASH PRURITIC 97
321 APPENDICITIS 96
322 HYPOMANIA 96
323 RESPIRATION ABNORMAL 96
324 BRONCHIAL HYPERREACTIVITY 95
325 ACCIDENTAL EXPOSURE TO PRODUCT 94
326 CARDIAC ARREST 94
327 CARDIOGENIC SHOCK 93
328 INTERVERTEBRAL DISC DEGENERATION 93
329 NEUROLOGICAL SYMPTOM 93
330 PRODUCT DOSE OMISSION IN ERROR 93
331 HIP FRACTURE 92
332 INJECTION SITE BRUISING 92
333 DEVICE ISSUE 91
334 LIMB INJURY 91
335 ROAD TRAFFIC ACCIDENT 91
336 THROAT CLEARING 91
337 VASCULITIS 91
338 MYASTHENIA GRAVIS 90
339 THERAPY CESSATION 90
340 BLOOD CREATININE INCREASED 89
341 MITE ALLERGY 89
342 DIVERTICULITIS 87
343 DRY THROAT 87
344 MUSCULOSKELETAL PAIN 87
345 TRANSIENT ISCHAEMIC ATTACK 87
346 APPENDICOLITH 86
347 BLOOD URIC ACID INCREASED 86
348 BRONCHOSPASM 86
349 DECREASED ACTIVITY 86
350 LUNG OPACITY 86
351 MULTIPLE ORGAN DYSFUNCTION SYNDROME 86
352 BLOOD PRESSURE SYSTOLIC INCREASED 85
353 CARDIAC FAILURE 85
354 EMOTIONAL DISTRESS 85
355 INFUSION SITE ERYTHEMA 85
356 PNEUMOTHORAX 85
357 RETCHING 85
358 AORTIC STENOSIS 84
359 BLOOD IMMUNOGLOBULIN E INCREASED 84
360 CONJUNCTIVITIS 84
361 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 84
362 INJECTION SITE PRURITUS 84
363 RIB FRACTURE 84
364 ARTERIOSCLEROSIS 83
365 BLOOD PHOSPHORUS INCREASED 83
366 BRONCHIAL SECRETION RETENTION 83
367 FLATULENCE 83
368 HYPOPHOSPHATAEMIA 83
369 INTERSTITIAL LUNG DISEASE 83
370 IRON DEFICIENCY ANAEMIA 83
371 RALES 83
372 ANOSMIA 82
373 HYPERPHOSPHATAEMIA 82
374 POLLAKIURIA 82
375 UPPER LIMB FRACTURE 81
376 HEART RATE IRREGULAR 80
377 PANIC ATTACK 80
378 POOR QUALITY SLEEP 80
379 PRODUCT SUBSTITUTION ISSUE 80
380 TOTAL LUNG CAPACITY ABNORMAL 80
381 BLISTER 79
382 EAR PAIN 79
383 FEELING COLD 79
384 OSTEOPENIA 79
385 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 79
386 PRODUCT CONFUSION 79
387 INFUSION SITE SWELLING 78
388 LUNG HYPERINFLATION 78
389 NEURITIS 78
390 VENTRICULAR FIBRILLATION 78
391 ARTHROPATHY 77
392 CHEST X-RAY ABNORMAL 77
393 DRUG ADMINISTRATION ERROR 77
394 GAIT INABILITY 77
395 MYCOTIC ALLERGY 77
396 ORAL DISCOMFORT 77
397 DEPRESSED MOOD 76
398 LUNG INFECTION 76
399 PLATELET COUNT DECREASED 76
400 TROPONIN INCREASED 76
401 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 75
402 AORTIC VALVE STENOSIS 75
403 BLOOD POTASSIUM DECREASED 75
404 ULCER 75
405 EYE DISORDER 74
406 FEEDING DISORDER 74
407 HYPERLIPIDAEMIA 74
408 NORMOCHROMIC NORMOCYTIC ANAEMIA 74
409 PULMONARY ALVEOLAR HAEMORRHAGE 74
410 ACCIDENTAL OVERDOSE 73
411 LYMPHADENOPATHY 73
412 MUSCULOSKELETAL CHEST PAIN 73
413 RIGHT ATRIAL HYPERTROPHY 73
414 RIGHT VENTRICULAR HYPERTROPHY 73
415 SPIROMETRY ABNORMAL 73
416 SPUTUM PURULENT 73
417 SPINAL OPERATION 72
418 ASPARTATE AMINOTRANSFERASE INCREASED 71
419 INFLAMMATION 71
420 IRON DEFICIENCY 71
421 PULMONARY VASCULITIS 71
422 THERAPY NON-RESPONDER 71
423 TOTAL LUNG CAPACITY DECREASED 71
424 URINARY RETENTION 71
425 WHITE BLOOD CELL COUNT DECREASED 71
426 ANALGESIC THERAPY 70
427 ATELECTASIS 70
428 INFUSION RELATED REACTION 70
429 ACUTE RESPIRATORY FAILURE 69
430 DRUG THERAPY 69
431 DYSURIA 69
432 EYE SWELLING 69
433 FOOT FRACTURE 69
434 GLAUCOMA 69
435 BLOOD PRESSURE FLUCTUATION 68
436 GASTROINTESTINAL HAEMORRHAGE 68
437 LETHARGY 68
438 ORAL HERPES 68
439 BLOOD PRESSURE ABNORMAL 67
440 LIP SWELLING 67
441 THERAPEUTIC PRODUCT EFFECT DECREASED 67
442 GLOSSODYNIA 66
443 KNEE ARTHROPLASTY 66
444 SINUS PAIN 66
445 SKIN DISCOLOURATION 66
446 THERAPEUTIC RESPONSE SHORTENED 66
447 WHITE BLOOD CELL COUNT INCREASED 66
448 LIMB DISCOMFORT 65
449 INSURANCE ISSUE 64
450 OROPHARYNGEAL DISCOMFORT 64
451 INTESTINAL OBSTRUCTION 63
452 LUNG CONSOLIDATION 63
453 TOOTH ABSCESS 63
454 ARRHYTHMIA 62
455 BLOOD URINE PRESENT 62
456 EXPOSURE VIA SKIN CONTACT 62
457 GASTROENTERITIS VIRAL 62
458 INTERCEPTED MEDICATION ERROR 62
459 LIVER DISORDER 62
460 TRICUSPID VALVE INCOMPETENCE 62
461 DEMENTIA 61
462 IRRITABILITY 61
463 SPINAL FRACTURE 61
464 ANGIOEDEMA 60
465 EXERCISE TOLERANCE DECREASED 60
466 NASAL OBSTRUCTION 60
467 BLOOD CALCIUM INCREASED 59
468 DEVICE DELIVERY SYSTEM ISSUE 59
469 HAEMATOCHEZIA 59
470 INTENTIONAL OVERDOSE 59
471 LUNG INFILTRATION 59
472 PRESYNCOPE 58
473 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 57
474 INJECTION SITE HAEMORRHAGE 57
475 KIDNEY INFECTION 57
476 MYCOBACTERIUM AVIUM COMPLEX INFECTION 57
477 RESPIRATORY DISTRESS 57
478 ANTACID THERAPY 56
479 ANTICOAGULANT THERAPY 56
480 CLOSTRIDIUM DIFFICILE INFECTION 56
481 CROHN^S DISEASE 56
482 DIVERTICULUM 56
483 DRUG DOSE OMISSION BY DEVICE 56
484 HYSTERECTOMY 56
485 RENAL IMPAIRMENT 56
486 SLEEP DISORDER THERAPY 56
487 DERMATITIS CONTACT 55
488 BACK INJURY 54
489 HEAD DISCOMFORT 54
490 LOCALISED INFECTION 54
491 BLINDNESS 53
492 BREAST CANCER 53
493 CAPILLARITIS 53
494 CATARACT OPERATION 53
495 COVID-19 PNEUMONIA 53
496 DISTURBANCE IN ATTENTION 53
497 GASTRIC DISORDER 53
498 HERNIA 53
499 OBSTRUCTIVE SLEEP APNOEA SYNDROME 53
500 PRODUCT PRESCRIBING ISSUE 53
501 PRODUCT TASTE ABNORMAL 53
502 PULMONARY HYPERTENSION 53
503 RESTRICTIVE PULMONARY DISEASE 53
504 SENSITIVITY TO WEATHER CHANGE 53
505 SINUSITIS FUNGAL 53
506 SUICIDAL IDEATION 53
507 ANKLE FRACTURE 52
508 HYPERSOMNIA 52
509 LOWER RESPIRATORY TRACT CONGESTION 52
510 PERICARDIAL EFFUSION 52
511 RASH ERYTHEMATOUS 52
512 SKIN LACERATION 52
513 STAPHYLOCOCCAL INFECTION 52
514 CARDIOMYOPATHY 51
515 COLITIS ULCERATIVE 51
516 EMBOLISM VENOUS 51
517 EYE INFECTION 51
518 FEMALE GENITAL TRACT FISTULA 51
519 FRUSTRATION TOLERANCE DECREASED 51
520 PRODUCT AVAILABILITY ISSUE 51
521 RESPIRATORY SYNCYTIAL VIRUS INFECTION 51
522 WRIST FRACTURE 51
523 HYPOPNOEA 50
524 LIVER FUNCTION TEST INCREASED 50
525 MUSCULOSKELETAL DISCOMFORT 50
526 ORAL MUCOSAL BLISTERING 50
527 PAIN IN JAW 50
528 PARAESTHESIA ORAL 50
529 PLEURITIC PAIN 50
530 RENAL DISORDER 50
531 RESPIRATORY RATE INCREASED 50
532 TACHYARRHYTHMIA 50
533 ANGINA PECTORIS 49
534 IDIOPATHIC INTRACRANIAL HYPERTENSION 49
535 INJECTION SITE REACTION 49
536 PHARYNGEAL SWELLING 49
537 PNEUMONITIS 49
538 SYSTEMIC LUPUS ERYTHEMATOSUS 49
539 BLOOD GLUCOSE DECREASED 48
540 MENTAL DISORDER 48
541 NEUTROPENIA 48
542 SKIN DISORDER 48
543 THYROID DISORDER 48
544 TOOTH DISORDER 48
545 INJECTION SITE RASH 47
546 KYPHOSIS 47
547 MACULAR DEGENERATION 47
548 PROCEDURAL PAIN 47
549 RECTAL HAEMORRHAGE 47
550 RHONCHI 47
551 TONGUE DISCOMFORT 47
552 EXPOSURE DURING PREGNANCY 46
553 GASTROENTERITIS 46
554 INCREASED UPPER AIRWAY SECRETION 46
555 INTERVERTEBRAL DISC PROTRUSION 46
556 REHABILITATION THERAPY 46
557 SKIN CANCER 46
558 ADRENAL INSUFFICIENCY 45
559 ALLERGY TO ANIMAL 45
560 ASPIRATION 45
561 INFUSION SITE DISCHARGE 45
562 LIGAMENT SPRAIN 45
563 PSORIATIC ARTHROPATHY 45
564 RASH MACULAR 45
565 RESPIRATORY GAS EXCHANGE DISORDER 45
566 SALPINGO-OOPHORECTOMY UNILATERAL 45
567 TYPE 2 DIABETES MELLITUS 45
568 BLOOD SODIUM DECREASED 44
569 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 44
570 CRYING 44
571 HYPERVENTILATION 44
572 MICTURITION URGENCY 44
573 MOVEMENT DISORDER 44
574 PANCREATITIS 44
575 PNEUMONIA BACTERIAL 44
576 VITAL CAPACITY DECREASED 44
577 BRONCHIAL DISORDER 43
578 BRONCHOPULMONARY ASPERGILLOSIS 43
579 BUNDLE BRANCH BLOCK LEFT 43
580 CARDIOMEGALY 43
581 CHOKING SENSATION 43
582 DYSSTASIA 43
583 HYPOKALAEMIA 43
584 ISCHAEMIC CARDIOMYOPATHY 43
585 NERVE COMPRESSION 43
586 NICOTINE DEPENDENCE 43
587 NIGHT SWEATS 43
588 PULMONARY PAIN 43
589 SECONDARY IMMUNODEFICIENCY 43
590 FREQUENT BOWEL MOVEMENTS 42
591 INFUSION SITE HAEMORRHAGE 42
592 LABORATORY TEST ABNORMAL 42
593 SINUS OPERATION 42
594 SKIN ATROPHY 42
595 TREATMENT FAILURE 42
596 BACK DISORDER 41
597 BLOOD IRON DECREASED 41
598 EOSINOPHIL COUNT ABNORMAL 41
599 INFUSION SITE BRUISING 41
600 MATERNAL EXPOSURE DURING PREGNANCY 41
601 POLYP 41
602 PRODUCT ADMINISTRATION ERROR 41
603 TOOTHACHE 41
604 URINARY INCONTINENCE 41
605 ANHEDONIA 40
606 CORONARY ARTERY DISEASE 40
607 DEVICE USE ISSUE 40
608 HEREDITARY ANGIOEDEMA 40
609 INFUSION SITE PRURITUS 40
610 IRRITABLE BOWEL SYNDROME 40
611 LOWER LIMB FRACTURE 40
612 NASAL DISCHARGE DISCOLOURATION 40
613 OXYGEN SATURATION ABNORMAL 40
614 PROSTATE CANCER 40
615 SARS-COV-2 TEST POSITIVE 40
616 ANAL INCONTINENCE 39
617 CORONAVIRUS INFECTION 39
618 EAR DISCOMFORT 39
619 JOINT STIFFNESS 39
620 PRODUCT COMMUNICATION ISSUE 39
621 SCIATICA 39
622 TOOTH INFECTION 39
623 BLOOD PRESSURE DIASTOLIC INCREASED 38
624 CARDIAC OPERATION 38
625 HIP ARTHROPLASTY 38
626 OCULAR DISCOMFORT 38
627 PHARYNGEAL OEDEMA 38
628 PULMONARY THROMBOSIS 38
629 WOUND 38
630 ACNE 37
631 CONCUSSION 37
632 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 37
633 DRUG DEPENDENCE 37
634 INJURY 37
635 NASAL DISORDER 37
636 SNORING 37
637 THIRST 37
638 ACUTE MYOCARDIAL INFARCTION 36
639 BODY TEMPERATURE INCREASED 36
640 BONE DENSITY DECREASED 36
641 CARDIAC PACEMAKER INSERTION 36
642 ECCHYMOSIS 36
643 ORAL DISORDER 36
644 PARANASAL SINUS HYPERSECRETION 36
645 POOR VENOUS ACCESS 36
646 PRODUCT USE COMPLAINT 36
647 SEPTIC SHOCK 36
648 TASTE DISORDER 36
649 WEIGHT FLUCTUATION 36
650 ADVERSE REACTION 35
651 DIPLOPIA 35
652 DISORIENTATION 35
653 FORCED VITAL CAPACITY DECREASED 35
654 JOINT DISLOCATION 35
655 MULTIPLE SCLEROSIS RELAPSE 35
656 PHARYNGITIS STREPTOCOCCAL 35
657 SCAB 35
658 SKIN BURNING SENSATION 35
659 TERMINAL INSOMNIA 35
660 TONGUE DISCOLOURATION 35
661 CHROMATURIA 34
662 MALIGNANT NEOPLASM PROGRESSION 34
663 NIGHTMARE 34
664 RASH PAPULAR 34
665 BACTEROIDES INFECTION 33
666 BLOOD PRESSURE DIASTOLIC DECREASED 33
667 BODY TEMPERATURE DECREASED 33
668 COGNITIVE DISORDER 33
669 COLITIS 33
670 CONGENITAL HIATUS HERNIA 33
671 DIZZINESS POSTURAL 33
672 DRUG EFFECT LESS THAN EXPECTED 33
673 DYSKINESIA 33
674 FACIAL PAIN 33
675 IMPAIRED GASTRIC EMPTYING 33
676 IMPAIRED HEALING 33
677 IMPAIRED WORK ABILITY 33
678 NASAL SEPTUM DEVIATION 33
679 PNEUMONIA ASPIRATION 33
680 RECTAL PROLAPSE 33
681 RENAL INJURY 33
682 STAPHYLOCOCCUS TEST POSITIVE 33
683 TOOTH EXTRACTION 33
684 ASTHMATIC CRISIS 32
685 DEVICE OCCLUSION 32
686 EOSINOPHILIC PNEUMONIA CHRONIC 32
687 FLANK PAIN 32
688 FULL BLOOD COUNT DECREASED 32
689 HAEMATOMA 32
690 HOSPICE CARE 32
691 INTRAOCULAR PRESSURE INCREASED 32
692 LUNG NEOPLASM 32
693 MULTIPLE FRACTURES 32
694 NASAL OEDEMA 32
695 PRODUCT ADMINISTRATION INTERRUPTED 32
696 RENAL CYST 32
697 STENT PLACEMENT 32
698 APHASIA 31
699 COLD SWEAT 31
700 DEAFNESS 31
701 FAECES DISCOLOURED 31
702 PRODUCT DISTRIBUTION ISSUE 31
703 PROLONGED EXPIRATION 31
704 PULMONARY ARTERIAL HYPERTENSION 31
705 RED BLOOD CELL COUNT DECREASED 31
706 SCRATCH 31
707 TRANSAMINASES INCREASED 31
708 UPPER RESPIRATORY TRACT CONGESTION 31
709 VENOUS PRESSURE JUGULAR INCREASED 31
710 VIRAL UPPER RESPIRATORY TRACT INFECTION 31
711 VOCAL CORD DYSFUNCTION 31
712 CARBON DIOXIDE INCREASED 30
713 CONTRAINDICATED PRODUCT ADMINISTERED 30
714 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 30
715 INTERCEPTED DRUG PRESCRIBING ERROR 30
716 LYMPHOMA 30
717 MOOD ALTERED 30
718 NOCTURIA 30
719 PARKINSON^S DISEASE 30
720 PLASMA CELL MYELOMA 30
721 PLEURAL THICKENING 30
722 PRESCRIBED UNDERDOSE 30
723 RESPIRATORY TRACT IRRITATION 30
724 RESTLESS LEGS SYNDROME 30
725 SKIN LESION 30
726 SKIN REACTION 30
727 SUFFOCATION FEELING 30
728 THROMBOCYTOPENIA 30
729 TONGUE DISORDER 30
730 BLOOD PRESSURE SYSTOLIC ABNORMAL 29
731 BOWEL MOVEMENT IRREGULARITY 29
732 C-REACTIVE PROTEIN INCREASED 29
733 DEVICE DIFFICULT TO USE 29
734 GALLBLADDER DISORDER 29
735 GASTRITIS 29
736 HAEMOPHILUS INFECTION 29
737 HAND FRACTURE 29
738 HEPATIC CIRRHOSIS 29
739 HYPOKINESIA 29
740 INCORRECT PRODUCT STORAGE 29
741 INFUSION SITE EXTRAVASATION 29
742 INJECTION SITE MASS 29
743 KNEE OPERATION 29
744 MENTAL STATUS CHANGES 29
745 PANIC REACTION 29
746 PARANASAL SINUS DISCOMFORT 29
747 PERFUME SENSITIVITY 29
748 REVERSIBLE AIRWAYS OBSTRUCTION 29
749 ROTATOR CUFF SYNDROME 29
750 SJOGREN^S SYNDROME 29
751 SKIN ULCER 29
752 VITAMIN D DEFICIENCY 29
753 CARDIOVASCULAR DISORDER 28
754 DISABILITY 28
755 EYE DISCHARGE 28
756 FEBRILE NEUTROPENIA 28
757 FEV1/FVC RATIO DECREASED 28
758 HYPOSMIA 28
759 INTENTIONAL DEVICE MISUSE 28
760 NEEDLE ISSUE 28
761 NEPHROGENIC ANAEMIA 28
762 OXYGEN CONSUMPTION INCREASED 28
763 RESTLESSNESS 28
764 ANGER 27
765 ARTHROPOD BITE 27
766 CORONARY ARTERY OCCLUSION 27
767 CUSHINGOID 27
768 EOSINOPHILIC BRONCHITIS 27
769 GASTROINTESTINAL INFECTION 27
770 GINGIVAL PAIN 27
771 HAEMATURIA 27
772 HEPATIC STEATOSIS 27
773 NOCTURNAL DYSPNOEA 27
774 OXYGEN THERAPY 27
775 PRECANCEROUS CONDITION 27
776 PRODUCT PHYSICAL ISSUE 27
777 PSEUDOMONAS INFECTION 27
778 SKIN INFECTION 27
779 SYMPTOM RECURRENCE 27
780 VOCAL CORD DISORDER 27
781 ACCIDENT 26
782 ANEURYSM 26
783 BODY HEIGHT DECREASED 26
784 CARPAL TUNNEL SYNDROME 26
785 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 26
786 DEVICE FAILURE 26
787 DYSARTHRIA 26
788 ERUCTATION 26
789 EYE OPERATION 26
790 FEAR 26
791 HAEMORRHOIDS 26
792 HYPERGLYCAEMIA 26
793 HYPOPHAGIA 26
794 MENISCUS INJURY 26
795 MOUTH SWELLING 26
796 NERVE INJURY 26
797 PHOTOPHOBIA 26
798 QUALITY OF LIFE DECREASED 26
799 SKIN FISSURES 26
800 AORTIC ANEURYSM 25
801 BRADYCARDIA 25
802 CREPITATIONS 25
803 EAR PRURITUS 25
804 EXOSTOSIS 25
805 FOOD ALLERGY 25
806 PHARYNGITIS 25
807 RENAL PAIN 25
808 SENSATION OF FOREIGN BODY 25
809 SKIN IRRITATION 25
810 THERAPY CHANGE 25
811 TOOTH FRACTURE 25
812 VISUAL ACUITY REDUCED 25
813 AUTOIMMUNE DISORDER 24
814 DENTAL CARIES 24
815 EATING DISORDER 24
816 FEMUR FRACTURE 24
817 HYPERCHOLESTEROLAEMIA 24
818 HYPOAESTHESIA ORAL 24
819 INCORRECT ROUTE OF DRUG ADMINISTRATION 24
820 JOINT RANGE OF MOTION DECREASED 24
821 MALIGNANT MELANOMA STAGE 0 24
822 MENTAL IMPAIRMENT 24
823 ORAL FUNGAL INFECTION 24
824 PARALYSIS 24
825 POST-TRAUMATIC STRESS DISORDER 24
826 SPINAL COMPRESSION FRACTURE 24
827 BRAIN FOG 23
828 CHOLECYSTECTOMY 23
829 CONCOMITANT DISEASE AGGRAVATED 23
830 EMERGENCY CARE 23
831 FOOD POISONING 23
832 HYPOMAGNESAEMIA 23
833 INCORRECT DOSE ADMINISTERED BY DEVICE 23
834 LEUKOPENIA 23
835 MUSCLE STRAIN 23
836 MUSCULOSKELETAL DISORDER 23
837 PHOTOSENSITIVITY REACTION 23
838 PLEURISY 23
839 POST PROCEDURAL COMPLICATION 23
840 RENAL NEOPLASM 23
841 SINUS HEADACHE 23
842 SKIN ABRASION 23
843 SPINAL OSTEOARTHRITIS 23
844 TOOTH LOSS 23
845 TRANSFUSION 23
846 VENTRICULAR HYPERTROPHY 23
847 WITHDRAWAL SYNDROME 23
848 ALANINE AMINOTRANSFERASE INCREASED 22
849 BEDRIDDEN 22
850 BRONCHITIS CHRONIC 22
851 COLON CANCER 22
852 CORONARY ARTERIAL STENT INSERTION 22
853 DELIRIUM 22
854 EOSINOPHIL COUNT 22
855 EXPIRATORY RESERVE VOLUME DECREASED 22
856 GLYCOSYLATED HAEMOGLOBIN INCREASED 22
857 HILAR LYMPHADENOPATHY 22
858 INCREASED APPETITE 22
859 INFUSION SITE INFECTION 22
860 INFUSION SITE MASS 22
861 INHALATION THERAPY 22
862 INJECTION SITE URTICARIA 22
863 LARGE INTESTINE POLYP 22
864 METASTASES TO CENTRAL NERVOUS SYSTEM 22
865 PAROSMIA 22
866 PELVIC FRACTURE 22
867 SMOKE SENSITIVITY 22
868 TENDERNESS 22
869 TENDONITIS 22
870 ABDOMINAL TENDERNESS 21
871 BONE DISORDER 21
872 DEMENTIA ALZHEIMER^S TYPE 21
873 EMERGENCY CARE EXAMINATION 21
874 IMMUNE SYSTEM DISORDER 21
875 LUMBAR VERTEBRAL FRACTURE 21
876 LUNG OPERATION 21
877 NASAL DISCOMFORT 21
878 NASAL DRYNESS 21
879 PERIPHERAL COLDNESS 21
880 PHARYNGEAL DISORDER 21
881 SLUGGISHNESS 21
882 SMALL INTESTINAL OBSTRUCTION 21
883 SQUAMOUS CELL CARCINOMA 21
884 STRIDOR 21
885 VITREOUS FLOATERS 21
886 ABDOMINAL PAIN LOWER 20
887 BIPOLAR DISORDER 20
888 CARDIAC FLUTTER 20
889 DEVICE BREAKAGE 20
890 DEVICE INFUSION ISSUE 20
891 EAR CONGESTION 20
892 ESSENTIAL HYPERTENSION 20
893 EYE HAEMORRHAGE 20
894 FRACTURE 20
895 HAEMATEMESIS 20
896 HIP SURGERY 20
897 HUNGER 20
898 INCORRECT PRODUCT ADMINISTRATION DURATION 20
899 INITIAL INSOMNIA 20
900 LUNG DIFFUSION DISORDER 20
901 LUNG DIFFUSION TEST DECREASED 20
902 MOUTH ULCERATION 20
903 MULTIPLE SCLEROSIS 20
904 ORAL INFECTION 20
905 OSTEONECROSIS 20
906 PAIN OF SKIN 20
907 PANCYTOPENIA 20
908 PRURITUS GENERALISED 20
909 RASH GENERALISED 20
910 TONGUE COATED 20
911 UVEITIS 20
912 WRONG PRODUCT ADMINISTERED 20
913 ASPERGILLUS INFECTION 19
914 BASAL CELL CARCINOMA 19
915 BLOOD MAGNESIUM DECREASED 19
916 CLOSTRIDIUM DIFFICILE COLITIS 19
917 DERMATITIS 19
918 DEVICE LEAKAGE 19
919 GASTRIC ULCER 19
920 GASTROINTESTINAL PAIN 19
921 INFUSION SITE WARMTH 19
922 LUNG ADENOCARCINOMA STAGE IV 19
923 MELAENA 19
924 NECK SURGERY 19
925 OTORRHOEA 19
926 PRE-EXISTING CONDITION IMPROVED 19
927 RED BLOOD CELL SEDIMENTATION RATE INCREASED 19
928 RESPIRATORY TRACT INFLAMMATION 19
929 SENSORY DISTURBANCE 19
930 SKIN HAEMORRHAGE 19
931 TACHYPNOEA 19
932 VAGINAL HAEMORRHAGE 19
933 WOUND INFECTION 19
934 ANTINUCLEAR ANTIBODY POSITIVE 18
935 AORTIC ARTERIOSCLEROSIS 18
936 ATOPY 18
937 ATYPICAL PNEUMONIA 18
938 BLOOD GLUCOSE ABNORMAL 18
939 COLONOSCOPY 18
940 DYSPNOEA AT REST 18
941 FACE OEDEMA 18
942 FLUID OVERLOAD 18
943 GINGIVAL DISORDER 18
944 HYPERPARATHYROIDISM SECONDARY 18
945 INCORRECT DRUG ADMINISTRATION RATE 18
946 INTERNAL HAEMORRHAGE 18
947 LYME DISEASE 18
948 OESOPHAGEAL CANDIDIASIS 18
949 OROPHARYNGEAL CANDIDIASIS 18
950 RED BLOOD CELL COUNT INCREASED 18
951 SENSITIVE SKIN 18
952 STEROID DEPENDENCE 18
953 TERMINAL STATE 18
954 VITAMIN D DECREASED 18
955 ABNORMAL DREAMS 17
956 ANAPHYLACTIC SHOCK 17
957 BLADDER CANCER 17
958 BLINDNESS UNILATERAL 17
959 BLOOD PRESSURE DIASTOLIC ABNORMAL 17
960 BURSITIS 17
961 CATHETERISATION CARDIAC 17
962 DEVICE USE CONFUSION 17
963 EOSINOPHILIC OESOPHAGITIS 17
964 FOOT DEFORMITY 17
965 GASTROINTESTINAL WALL THICKENING 17
966 HALLUCINATION, VISUAL 17
967 IMPAIRED DRIVING ABILITY 17
968 INCONTINENCE 17
969 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 17
970 INJECTION SITE WARMTH 17
971 INSPIRATORY CAPACITY ABNORMAL 17
972 INTERCEPTED DRUG ADMINISTRATION ERROR 17
973 LEUKOCYTOSIS 17
974 LYMPHADENOPATHY MEDIASTINAL 17
975 MASS 17
976 NASAL INFLAMMATION 17
977 NEUTROPHIL COUNT DECREASED 17
978 PALLOR 17
979 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 17
980 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17
981 PRODUCT PREPARATION ERROR 17
982 PRODUCT RESIDUE PRESENT 17
983 PSYCHOMOTOR HYPERACTIVITY 17
984 SOCIAL PROBLEM 17
985 SPINAL PAIN 17
986 SPUTUM RETENTION 17
987 TENDON RUPTURE 17
988 TIBIA FRACTURE 17
989 VENTRICULAR EXTRASYSTOLES 17
990 APPETITE DISORDER 16
991 ATRIAL SEPTAL DEFECT 16
992 BILIARY DILATATION 16
993 BLADDER DISORDER 16
994 CYST 16
995 DRUG WITHDRAWAL SYNDROME 16
996 EYE INJURY 16
997 GLOMERULAR FILTRATION RATE DECREASED 16
998 GLUCOSE TOLERANCE IMPAIRED 16
999 GRANULOMATOSIS WITH POLYANGIITIS 16